NCT04806906View on ClinicalTrials.gov

Pilot Study of CC 486 (Oral Azacitidine) Plus BSC as Maintenance After sc Azacitidine in Elderly HR-IPSS-R MDS Patients

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

March 24, 2021

Primary Completion Date

August 31, 2024

Study Completion Date

December 31, 2024

Conditions
MDSCMML
Interventions
DRUG

CC-486

Investigational product will be dispensed on Day 1 of each treatment cycle. 300 mg CC-486 QD for 14 days of each 28-day treatment cycle

Trial Locations (1)

50134

AOU Careggi- University of Florence, Florence

All Listed Sponsors
lead

University of Florence

OTHER